首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

International Journal Of Hematology

International Journal Of Hematology杂志,由Springer Singapore出版,于2001年创刊,Monthly,出版语言English,ISSN:0925-5710,E-ISSN:1865-3774。

投稿咨询
International Journal Of Hematology
International Journal Of Hematology
International Journal Of Hematology
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
4区
影响因子
1.9
CiteScore
3.4
期刊收录
SCI、SCIE

International Journal Of Hematology(中文译名:《国际血液学杂志》),ISSN:0925-5710,EISSN:1865-3774,是Springer Singapore出版的国际性学术期刊,创刊于2001年,以Monthly形式稳定发行,2026年总发文量约205篇。该刊采用非OA开放访问,学科归属为医学 - 血液学。该刊是医学、血液学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达1.9,2025年期刊CiteScore为3.4,2025年期刊自引率约10.5%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。International Journal Of Hematology长期聚焦医学、血液学及相关产业的技术应用前沿,平均审稿周期约6.0个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、血液学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,JapanUSA、CHINA MAINLAND、South Korea、Italy、Taiwan、Austria等为核心发文国家与地区;NAGOYA UNIVERSITYNATIONAL CANCER CENTER - JAPAN、KYOTO UNIVERSITY、UNIVERSITY OF TOKYO、KYUSHU UNIVERSITY、OSAKA UNIVERSITY、JICHI MEDICAL UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
HEMATOLOGY 血液学
4区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
HEMATOLOGY 血液学
4区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
HEMATOLOGY 血液学
4区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q3 69 / 103

33.5

学科:HEMATOLOGY SCIE Q3 59 / 103

43.2

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q3 63 / 99

36.9

学科:HEMATOLOGY SCIE Q3 56 / 100

44.5


中国学者近期发文

1
Venetoclax-based combination regimens for therapy-related myeloid neoplasm

Author:Zhang, Tongtong; Yu, Yan; Fang, Yanglan; Xiao, Jinyan; Liu, Hong; Zhou, Haixia; Xu, Mingzhu

Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12185-025-04152-4

2
Treatment pathways and clinical outcomes in newly diagnosed multiple myeloma outside Europe and North America: The INTEGRATE study (mAR, 10.1007/s12185-025-03972-8, 2025

Author:Kim, Kihyun; Verburgh, Estelle; Mitina, Tatiana; Chen, Wenming; Yeh, Su-Peng; Schutz, Natalia; Alsharif, Fahad; Chng, Wee Joo; Huang, Zhongwen; Beksac, Meral

Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s12185-025-04012-1

3
Early withdrawal immunosuppression improved mixed chimerism in stem cell transplantation for pediatric aplastic anemi

Author:Wang, Xinan; Qin, Xia; Luo, Chengjuan; Luo, Changying; Wang, Jianmin; Huang, Xiaohang; Mi, Qiang; Lin, Yuchen; Chen, Jing

Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s12185-025-03971-9

4
Use of activated partial thrombin time and prothrombin time for quality assessment of fresh frozen plasm

Author:Layibo, Yao; Padaro, Essohana; Magnang, Hezouwe; Badassan, Magnime; Kueviakoe, Irenee M. D.; Mawussi, Koffi; Feteke, Lochina

Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s12185-025-03984-4

5
Differences in response to immunotherapy drugs including blinatumomab and inotuzumab ozogamicin in B-ALL patient

Author:Liu, Zhi-Yin; Yan, Ze-Ying; Li, Jian-Feng; Zhu, Yong-Mei; Yang, Guang; Sun, Hai-Min; An, Ran; Tian, Jie; Wang, Ying; Xu, Xiao-Qian; Chen, Li; Bao, Wei-Ying; Zhang, Su-Jiang

Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s12185-025-03983-5

6
Treatment pathways and clinical outcomes in newly diagnosed multiple myeloma outside Europe and North America: The INTEGRATE stud

Author:Kim, Kihyun; Verburgh, Estelle; Mitina, Tatiana; Chen, Wenming; Yeh, Su-Peng; Schutz, Natalia; Alsharif, Fahad; Chng, Wee Joo; Huang, Zhongwen; Beksac, Meral

Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s12185-025-03972-8

7
Exploration of the association between 91 inflammatory proteins and immune thrombocytopenia: a two-sample Mendelian randomization analysi

Author:Qin, Aihua; Liu, Dan; Tang, Heshan; Li, Jinqi; Qiu, Liling; Qian, Baohua; Zang, Yan

Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s12185-025-03987-1

8
Zanubrutinib in Japanese treatment-naive and relapsed/refractory patients with Waldenström macroglobulinemia and CLL/SL

Author:Izutsu, Koji; Ishikawa, Takayuki; Shimada, Kazuyuki; Kubo, Kohmei; Kondo, Takeshi; Fujimoto, Katsuya; Fujisaki, Tomoaki; Kurahashi, Shingo; Nagafuji, Koji; Sakai, Rika; Jo, Tatsuro; Nakazato, Tomonori; Sunami, Kazutaka; Kasahara, Senji; Cohen, Aileen; Takai, Motohisa; Zhong, Jinhua; Takeuchi, Masahiro

Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s12185-025-03925-1

9
The medium-fluorescence reticulocyte ratio is an independent predictor of G6PD deficiency neonate

Author:Rao, Mingliang; Luo, Wenna; Wu, Baojing

Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s12185-025-03916-2

10
Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic leukemi

Author:Feng, Lin-sen; Li, Hui-yuan; Tang, Ai; Xu, Meng-li; Wang, San-bin

Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s12185-025-03915-3


在线咨询

International Journal Of Hematology

国际简称:INT J HEMATOL参考译名:国际血液学杂志

年发文量:205 CiteScore:3.4 是否预警:否 Gold OA文章占比:26.21% 研究类文章占比:88.29%

杂志社联系方式:SPRINGER TOKYO, 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, JAPAN, 102-0073

International Journal Of Hematology